Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
EMC$33.86-0.28(-0.82%)EMC Insurance Receives Insurity's Excellence in Operational Efficiency Award[12:01:00 PM ET]GCDT$0.14-0.04(-22.54%)Green Circle Decarbonize Technology Limited Issues Statement Regarding Unusual Market Activity[11:45:00 AM ET]KLAR$12.62-0.20(-1.52%)Klarna's flexible payment options now available at Adorama, giving creators more ways to fuel their next project Adorama, a leading photography, video, audio, drone, and computer retailer, and Klarna, the everyday finance network, today announced that Klarna is...[11:39:00 AM ET]DUK$124.48-0.51(-0.40%)Duke Energy Florida shares tips for warding off energy vampires, saving money This Halloween, Duke Energy Florida is reminding customers of the scary reality of energy "vampires" – appliances and electronics lurking throughout...[11:39:00 AM ET]FFR$1.07-0.06(-5.31%)FF EAI Robotics Ecosystem Completed its Acquisition of the Robotics Business of Faraday Future, Establish Nasdaq-Listed Humanoid and Bionic Robotics Platform FF EAI Robotics Ecosystem Inc. ("FFR") (NASDAQ: FFR), a U.S.-based Embodied AI robotics company, and Faraday Future Intelligent Electric Inc....[11:30:00 AM ET]MRK$141.25-4.03(-2.77%)Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Certain Patients With Advanced or Recurrent Endometrial Cancer[11:30:00 AM ET]FFR$1.07-0.06(-5.31%)Faraday Future Announces Completion of FF EAI Robotics Ecosystem's (FFR) Acquisition of Faraday Future's Robotics Business and Establishment of a Nasdaq-Listed Humanoid and Bionic Robotics Platform[11:30:00 AM ET]STGW$8.63-0.35(-3.90%)Stagwell (STGW) Acquires Freestar, Leading Publisher Advertising Services Company[11:30:00 AM ET]PGNY$28.37-0.60(-2.07%)New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model[11:25:22 AM ET]PII$55.04+0.21(+0.39%)POLARIS SIGNS OFF-ROAD CHAMPION KYLE CHANEY TO MULTI-YEAR RACING AGREEMENT WITH RZR FACTORY RACING[11:22:00 AM ET]LLY$1,280.18+6.72(+0.53%)Lilly declares fourth-quarter 2026 dividend The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2026 of $1.73 per share on outstanding...[11:19:00 AM ET]NWBO$0.15+0.00(+0.73%)Northwest Biotherapeutics Announces Expansion of Its Technical Team Northwest Biotherapeutics (OTCQB: NWBO) NWBio a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...[11:16:00 AM ET]

MGRX · NASDAQ

Mangoceuticals, Inc.

$0.22 -0.01 (-5.09%)

Company overview

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through its online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$4.9M
Employees
3
Headquarters
Dallas, TX
Website
mangorx.com
CEO
Jacob D. Cohen
Listed
March 21, 2023
P/E
-0.13
Dividend yield
0.00%

Company financials

Revenue
$414,579
Gross profit
$217,322
Operating income
-$17.4M
EBITDA
-$17.5M
Net income
-$19.2M
EPS
-$1.76
Total assets
$14.4M
Total debt
$294,023
Gross margin
52.42%
Net margin
-4,632.94%
Earnings yield
-800.00%

Price chart

0.190.470.741.021.29
MGRX 1D NASDAQ O0.25H0.26L0.23C0.23-0.01 (-5.12%)Vol300.42K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Type
Ticker Type Headline Source Published
MGRXMangoceuticals, Inc. Stock news Analyzing Mangoceuticals (NASDAQ:MGRX) & Quest Diagnostics (NYSE:DGX) Defense World
MGRXMangoceuticals, Inc. Stock news Mangoceuticals (NASDAQ: MGRX) closes 74% premium stock sale with warrants Defense World
MGRXMangoceuticals, Inc. Press release Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close GlobeNewswire
MGRXMangoceuticals, Inc. Stock news Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session Benzinga
MGRXMangoceuticals, Inc. Stock news Nike, Synaptics And 3 Stocks To Watch Heading Into Friday Benzinga
MGRXMangoceuticals, Inc. Stock news Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche GlobeNewsWire
MGRXMangoceuticals, Inc. Stock news Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST) Defense World
MGRXMangoceuticals, Inc. Legal MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire
MGRXMangoceuticals, Inc. Press release Mangoceuticals Inc.'s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets GlobeNewsWire
MGRXMangoceuticals, Inc. Press release Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets Newsfile Corp
MGRXMangoceuticals, Inc. Press release Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure GlobeNewsWire
MGRXMangoceuticals, Inc. Press release Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure Newsfile Corp
MGRXMangoceuticals, Inc. Press release Mangoceuticals' Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development GlobeNewsWire
MGRXMangoceuticals, Inc. Press release Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination GlobeNewsWire
MGRXMangoceuticals, Inc. Stock news Mangoceuticals (NASDAQ:MGRX) versus Lipocine (NASDAQ:LPCN) Financial Contrast Defense World
MGRXMangoceuticals, Inc. Stock news Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) Defense World
MGRXMangoceuticals, Inc. Stock news Mangoceuticals Stock Doubles After Texas Lawsuit Benzinga
MGRXMangoceuticals, Inc. Press release Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. GlobeNewsWire
MGRXMangoceuticals, Inc. Press release Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds GlobeNewsWire
MGRXMangoceuticals, Inc. Press release Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study GlobeNewsWire
See more
FAQ

Questions about Mangoceuticals, Inc.

What does Mangoceuticals, Inc. do?
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through its online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
What is MGRX's market cap?
Mangoceuticals, Inc. (MGRX) is a listed stock with a live quote. The latest market cap on this page is $4.9M.
Where is Mangoceuticals, Inc. headquartered?
Mangoceuticals, Inc. is headquartered in Dallas, TX.
How do I get MGRX news from the API?
Call GET /v1/news?tickers=MGRX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does MGRX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for MGRX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the MGRX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs